Minimally invasive BPH treatments
Water vapour therapy, urethral lift, aquablation and prostatic artery embolisation.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 5, 9, 8, 14, 16.
New guidelines and consensus this year
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and EvaluationJ Urol2026 Aug
- Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical ManagementJ Urol2026 Aug
- Society of Interventional Radiology (SIR) 2026 Practice Guidance Document for Prostatic Artery EmbolizationJ Vasc Interv Radiol2026 Jun 1
- Surgical and interventional management of bladder outlet obstruction related to benign prostatic hyperplasia: Systematic review of the literature and Clinical Practice Guidelines from the French Male LUTS Committee (CTMH)Fr J Urol2025 Nov
All papers from the last 12 months
183 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- The financial impact of surgical interventions for benign prostatic hyperplasia within a single NHS trustJ Med Econ2026 DecPMID 42387670
- Clinical outcomes following prostatic artery embolization in a Taiwanese cohort: association between current smoking and symptomatic improvementEur J Radiol2026 NovPMID 42561892
- Efficacy and Safety of Rezūm Water Vapor Thermal Ablation in Large and Small Prostates: A Multicenter Comparative Analysis of 2,725 PatientsJ Am Coll Surg2026 Nov 1PMID 42360199
- Invited Commentary: Should Rezūm Water Vapor Thermal Therapy Be Considered for Large and Very Large-Volume Benign Prostatic Hyperplasia?J Am Coll Surg2026 Nov 1PMID 42360197
- A systematic review and meta-analysis on the safety and efficacy of AquablationBJUI Compass2026 OctPMID 42851274Review
- Aquablation as salvage therapy for benign prostatic hyperplasia: an international multicentre studyBJU Int2026 Oct 7PMID 42843985
- [Prostate artery embolization-2026 update : Technique, evidence, and role in the treatment of benign prostatic hyperplasia]Radiologie (Heidelb)2026 Oct 7PMID 42841948Review
- How does PSA change after water vapor therapy? A systematic review and meta-analysisProstate Cancer Prostatic Dis2026 Oct 6PMID 42838990Review
- Reply to: prostatic artery embolization with N-butyl cyanoacrylate for benign prostatic hyperplasia: a success story that merits closer examinationRadiol Med2026 OctPMID 42742900
- A Prospective Randomized Study of Sexual and Ejaculatory Outcomes Following Water Vapor Therapy versus Holmium Laser Enucleation for Large-Volume Benign Prostatic Hyperplasia: ErratumJ Urol2026 OctPMID 42713892
More urology trends
All specialties →Antibody-drug conjugates in bladder cancer
Enfortumab vedotin and other ADCs in urothelial cancer.
Key point: Enfortumab vedotin-related adverse events, particularly cutaneous toxicity, were associated with favorable clinical outcomes, but findings are hypothesis-generating and need prospective confirmation.
MRI in prostate cancer diagnosis
MRI before biopsy and in screening for prostate cancer.
Transperineal prostate biopsy
Biopsy through the perineum instead of the rectum.
Key point: Transperineal biopsy is the recommended approach when technically feasible.
Thulium fibre laser
Thulium fibre laser for stone lithotripsy and prostate surgery.
Key point: ThuFLEP and conventional HoLEP are clinically comparable, with no definitive superiority of either laser.
PSMA PET in prostate cancer
PSMA PET imaging for staging and recurrence of prostate cancer.
Key point: PSMA-PET/CT is recommended only when PSA exceeds 0.2 μg/L, reporting should follow PSMA-RADS, and it is preferred over lymph-node dissection for staging.
Male infertility
Male infertility and trends in semen quality.
Key point: Male infertility management should be couple-centered, integrating the female partner's reproductive timeline to avoid preventable delays in effective therapy.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"benign prostatic"[tiab] AND (Rezum[tiab] OR "water vapor"[tiab] OR Urolift[tiab] OR "prostatic urethral lift"[tiab] OR aquablation[tiab] OR "prostatic artery embolization"[tiab] OR "prostatic artery embolisation"[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.